January 5, 2022
Members of the Weill Center for Metabolic Health, Dr. Rebecca Craig-Schapiro, Dr. Shahin Rafii, and Dr. Qiao Zhou, have received a two-year $500,000 grant from JDRF to evaluate an innovative approach to islet cell transplantation, an experimental treatment for difficult-to-control type 1 diabetes. The research will be conducted in mouse models of this disease.
Faculty Honors and Awards
December 30, 2021
Metabolic Center member Dr. Louis Aronne, the Sanford I. Weill Professor of Metabolic Research and a professor of clinical medicine, has been awarded the Clinician of the Year Award by the Clinical Management of Obesity Section of The Obesity Society. The Clinician of the Year Award signifies excellence in the practice of obesity medicine and distinguishes a physician as having achieved a high level of competency and understanding in obesity care.
Researchers Identify Significant Differences in Tumor Characteristics Between Younger and Older Cancer Patients
December 7, 2021
Investigators led by our Metabolic Center member Dr. Olivier Elemento have identified significant differences in the molecular characteristics of tumors from younger and older cancer patients across several cancer types. Their research, published Dec. 7 in Cell Reports, suggests that cancer treatment could potentially be tailored by age. The study also identified pre-existing drugs that could target mutations predominantly found in younger cancer patients—promising candidates for future clinical research.
December 6, 2021
A new protein variant underlies the ability of gastric cancers to resist an otherwise effective family of chemotherapy drugs, according to a study by a multidisciplinary team including co-senior author Dr. Olivier Elemento, a member of the Weill Center for Metabolic Health. The results suggest a treatment strategy that could improve the prognoses of many patients with cancer.
October 28, 2021
Loss of the gene SATB2 contributes to changes in stem cells that typically develop into the inner lining of the colon, or large intestine, transforming them into a cell type that normally lines a portion of the small intestine called the ileum, according to new preclinical research led by our Metabolic Center member, Dr. Joe Zhou, in a study published Sept. 27 in Cell Stem Cell.